Brain-derived neurotrophic factor treatment increases the skeletal muscle glucose transporter 4 protein expression in mice.

Suwa, M; Yamamoto, K-I; Nakano, H; Sasaki, H; Radak, Z; Kumagai, S

Suwa, M; Yamamoto, K-I; Nakano, H; Sasaki, H; Radak, Z; Kumagai, S.

Affiliation

Suwa M; Faculty of Life Design, Tohoku Institute of Technology, Taihaku-ku, Sendai, Miyagi, Japan. suwa-m@tohtech.ac.jp

Physiol Res ; 59(4): 619-623, 2010.

Article in En | MEDLINE | ID: mdl-19929144

Subject(s)

Brain-Derived Neurotrophic Factor/administration & dosage; Glucose Transporter Type 4/metabolism; Muscle, Skeletal/drug effects; Animals; Eating/drug effects; Female; Injections, Subcutaneous; Mice; Mice, Inbred ICR; Muscle, Skeletal/enzymology; Muscle, Skeletal/metabolism; Time Factors; Up-Regulation; Weight Gain/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Muscle, Skeletal / Brain-Derived Neurotrophic Factor / Glucose Transporter Type 4 Limits: Animals Language: En Journal: Physiol Res Journal subject: FISIOLOGIA Year: 2010 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links